Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Net revenues $ 31,803,387 $ 15,864,483
Cost of sales 10,146,565 7,091,942
Gross profit 21,656,822 8,772,541
Operating expenses:    
Research and development 13,743,826 10,850,958
Selling, general and administrative 14,348,890 14,807,472
Loss on settlement of accounts receivable   3,986,518
Total operating expenses 28,092,716 29,644,948
Operating loss (6,435,894) (20,872,407)
Non-operating (expenses) income:    
Interest expense (4,706,056) (2,950,501)
Change in fair value of derivative liabilities (1,199,000) 893,000
Foreign currency transaction loss (73,640) (126,928)
Other income (expense), net 93,291 (15,451)
Total non-operating expenses (5,885,405) (2,199,880)
Loss before income taxes (12,321,299) (23,072,287)
Income tax (benefit) expense (303,933) 866,102
Net loss $ (12,017,366) $ (23,938,389)
Net loss per basic and diluted common share outstanding $ (0.19) $ (0.44)
Basic and diluted weighted average common shares outstanding 63,323,127 53,861,981